semaglutide ruling - Uses | Limitations Knowledge Nugget: Evergreening in Patents—Why
Description
Reduced SCFA production means less GLP-1 stimulation from L-cells
DREAMS-3 head-to-head showed superiority over semaglutide 1 mg with 10.3% vs 6.0% at 32 weeks
10.2337/dc16-1324 39 De VadderF.Kovatcheva-DatcharyP.GoncalvesD.VineraJ.ZitounC.DuchamptA.et al (2014)
Theres a big difference between using these drugs primarily for boosting metabolic rate and using them specifically to manage blood sugar
They made me feel at ease and answer all my questions very thoroughly
Thats where Semaglutide can be a powerful tool
